Evidence map›Paper›PMID 26700440›Full record

ReviewClinical journal of the American Society of Nephrology : CJASN2016

B Cells, Antibodies, and More.

William Hoffman, Fadi G Lakkis, Geetha Chalasani

Open access · greenAbstract readReview
In one paragraph

Review in Clinical journal of the American Society of Nephrology : CJASN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 227 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
227citing papers in PubMed, 3 pooled it
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

227 citing papers in PubMed, 3 syntheses or guidelines pooled it, 471 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Sex Steroid Hormone Regulation of T-Cell Function and Antitumor Immunity.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Immune Cells in Preeclampsia.International journal of molecular sciences · 2025
    Review

167 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

William HoffmanDepartments of Medicine (Renal-Electrolyte).
Fadi G LakkisDepartments of Medicine (Renal-Electrolyte), Surgery, and Immunology, Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, and.
Geetha ChalasaniDepartments of Medicine (Renal-Electrolyte), Surgery, and Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, and Renal Section, Veterans Affairs Pittsburgh Health Care System, Pittsburgh, Pennsylvania gec12@pitt.edu.
University of Pittsburgh · USVA Pittsburgh Healthcare System · US

Funding

B Cells in the Pathogenesis of Allograft RejectionR01AI079177 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHALASANI, GEETHA · 2008 to 2021
$3.5M
NIAID NIH HHS R01 AI079177
6 · The paper itself

Abstract

B cells play a central role in the immunopathogenesis of glomerulonephritides and transplant rejection. B cells secrete antibodies that contribute to tissue injury via multiple mechanisms. In addition, B cells contribute to disease pathogenesis in autoimmunity and alloimmunity by presenting antigens as well as providing costimulation and cytokines to T cells. B cells also play an immunomodulatory role in regulating the immune response by secreting cytokines that inhibit disease onset and/or progression. B cell-targeted approaches for treating immune diseases of the kidney and other organs have gained significant momentum. However, much remains to be understood about B-cell biology in order to determine the timing, duration, and context of optimal therapeutic response to B cell-targeted approaches. In this review, we discuss the multifaceted roles of B cells as enhancers and regulators of immunity with relevance to kidney disease and transplantation.

Indexed as

Acute Kidney InjuryAnimalsAntibodiesAntigen-Presenting CellsB-Cell Activating FactorB-LymphocytesCell DifferentiationGlomerulonephritisGlomerulonephritis, MembranousHumansImmune ToleranceImmunity, CellularKidney TransplantationLupus NephritisLymphocyte ActivationAntibodiesB-Cell Activating FactorTNFSF13B protein, humanAntibodiesautoimmunityB-LymphocytesB regulatory cellscytokinesglomerulonephritisgraft rejectionimmune system diseasesplasma cellsT-Lymphocytes

Identifiers

PMID26700440
PMCPMC4702236
OpenAlexW2219152942

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.